Navellier & Associates’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
Navellier & Associates's GILD Position: Q4 2020 in Review
Navellier & Associates sold out of Gilead Sciences (GILD) in Q4 2020, closing a stake of 19,196 shares — an estimated $1.21M sold.
Navellier & Associates first reported a position in GILD in Q2 2013 and held it in 15 quarters. The position peaked at $4.43M in Q2 2020. 1,563 funds tracked by Wall St. Rank hold GILD as of Q4 2020.
- Navellier & Associates reported no remaining Gilead Sciences position as of Q4 2020 after selling out during the quarter.
- Navellier & Associates sold 19,196 Gilead Sciences shares in Q4 2020, an estimated $1.21M.
- Navellier & Associates first reported a position in Gilead Sciences in Q2 2013 and held it in 15 quarters.
- Navellier & Associates's Gilead Sciences position peaked at $4.43M in Q2 2020.
- 1,563 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2020.
Based on Navellier & Associates's 13F filing for Q4 2020, filed 5 Feb 2021.